Skip to main content
. 2019 Sep 10;9:13008. doi: 10.1038/s41598-019-49477-3

Table 1.

Characteristics of the discovery and replication mCRC cohorts.

Characteristics Canadian cohort Italian cohort
N = 167 % N = 250 %
Gender
   Male 110 66 162 65
   Female 57 34 88 35
Age (years)
   Mean 61.5 60.6
   Standard Deviation 10.2 10.3
   Range 29–86 26–75
   FOLFIRI 167 100 250 100
   Co-treatment 75 44.9 0 0
   Bevacizumab 69 92.0 0 0
   Other drug 6 8.0 0 0
Clinical outcomes (median in months)
   Progression-free survival 11 7
   Overall survival 24 15